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Abstract
Bacterial infection impairs the healing process, promoting the chronicity of inﬂammation and wounds. Because antibiotics fail to eradi-
cate bacteria, especially in bioﬁlm form, new therapeutic modalities may be required. In the present study, the effectiveness of bacterio-
therapy with Lactobacillus plantarum on infected chronic venous ulcers was investigated and its effects on interleukin (IL)-8 production
by cells from the ulcer bed and neutrophils isolated from peripheral blood that were previously challenged in vitro with Pseudomonas
aeruginosa and L. plantarum were studied. Topical application of L. plantarum culture to lesions (25–60 cm2) of 14 diabetic and 20 non-
diabetic patients induced debridement, granulation tissue formation and total healing after 30 days in 43% diabetics and in 50% non-dia-
betics. No signiﬁcant differences between the groups were observed. The cells from ulcer beds collected after treatment with L. planta-
rum for 10 days showed a decrease in the percentage of polymorphonuclear, apoptotic and necrotic cells and an enhancement of IL-8
production. IL-8 production by isolated neutrophils from these patients was compared with that in diabetics without ulcers, as well as
normal subjects under basal conditions, and after infection of polymorphonuclear cells with P. aeruginosa preincubated either with or
without L. plantarum. The basal values in diabetic and ulcer patients were higher than normal (p <0.001) and were increased by P. aeru-
ginosa infection in normal, diabetics (p <0.001) and non-diabetics with ulcers (p <0.01). Preincubation with L. plantarum decreased IL-8
production in patients with ulcers non-diabetic and diabetic (p <0.001). Lactobacillus plantarum treatment reduced wound bacterial load,
neutrophils, apoptotic and necrotic cells, modiﬁed IL-8 production and induced wound healing.
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Introduction
Chronic wounds are, by deﬁnition, wounds that remain in a
chronic inﬂammatory state and therefore fail to follow the
normal patterns of the healing process. Chronic wounds are
rarely, if ever, sterile and achieving wound sterility is often
an unrealistic and non-essential goal in wound care [1]. Bac-
teria infecting chronic wounds are producers of bioﬁlm and
so are extremely resistant both to antibiotics and to the
host immune response [2].
Polymorphonuclear neutrophil (PMN) leukocytes are
probably the most signiﬁcant components of the host
defence mounted against bioﬁlm-forming bacteria, and their
secretory and phagocytic arsenal often fails to eliminate bac-
teria in bioﬁlm, especially in diabetics [1].
Microbial products induce the secretion of inﬂammatory
mediators. One of the most important is interleukin (IL)-8, a
potent chemoattractant of neutrophils. In this way, infection
and inﬂammation contribute to the chronicity of the wound
[3]. It has been estimated by the National Institute of Health
of the USA that more than 80% of persistent bacterial infec-
tions are likely to involve bioﬁlms [2]. Chronic wound infec-
tions often do not respond to traditional antimicrobial
therapies [4], and new therapeutic modalities may be
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required [5]. Financial and operative limitations in our hospi-
tals have led us to investigate an alternative therapy, namely,
bacteriotherapy with Lactobacillus plantarum, to debride
chronic wounds and diminish infection. Bacteriotherapy con-
sists of the use of harmless bacteria to displace pathogenic
organisms and it is considered to be a promising alternative
to ﬁght infection [6–8].
We have previously demonstrated [9] the ability of the
probiotic organism L. plantarum to inhibit the pathogenic
activity of Pseudomonas aeruginosa both in vivo, using a burn
wound mouse model, and in vitro, indicating that L. plantarum
and/or its products are potential therapeutic agents for the
local treatment of P. aeruginosa burn infections.
It has also been demonstrated that L. plantarum and P. aeru-
ginosa induce antagonistic substances in the inﬂammatory
response [10]. We used therapy with L. plantarum because
Lactobacilli have an excellent overall safety record among
probiotics and no spontaneous L. plantarum infections have
been documented [11].
The present study aimed to evaluate the efﬁcacy of bac-
teriotherapy with L. plantarum culture on the chronic
infected leg ulcers of diabetic and non-diabetic patients and
to observe its effects on apoptosis, necrosis and IL-8 produc-
tion by the cells from the ulcer bed (CUB). In addition, IL-8
production was analyzed in peripheral blood PMN (PBPMN)
from patients with ulcers and compared with that in PBPMN
from normal and diabetic subjects without ulcers under basal
conditions, and after infection with P. aeruginosa either with
or without preincubation with L. plantarum.
Material and Methods
Patients
The study comprised male and female individuals aged 40–
70 years of age. Thirty-four patients from the plastic sur-
gery and burns unit of the ‘Zenon Santillan’ Hospital with a
chronic venous ulcer were included in a prospective uncon-
trolled study employing a local L. plantarum treatment.
Fourteen patients suffered from moderately controlled type
2 diabetes mellitus (glycaemia level: 1.50 ± 0.30 mg/mL,
HbA1C: 7.8 ± 2.1%) and the 20 remaining patients were
non-diabetic. Inclusion criteria included the presence of one
venous ulcer conﬁrmed by venous duplex ultrasound, with
a surface of 25–60 cm2, a bacterial load at a level >105
microorganisms per gram of tissue, which is generally
accepted to justify a diagnosis of infection and is an impor-
tant factor in delayed healing in chronic wounds [1], and
no signs of healing in the past 3 months, despite conven-
tional medical treatment.
Inclusion criteria comprised patients who had malignancy,
autoimmune disease, an inclination to bleed or bleeding dis-
ease, and serious systemic infection.
Ten diabetic patients with similar glycaemia levels with-
out lesions and 14 healthy subjects with normal glycaemia
levels attending the ‘Angel C. Padilla’ Hospital were
included as PBPMN donors. Both hospitals are located in
the city of San Miguel de Tucuma´n, Argentina. All patients
were informed about the aims of the study and provided
their consent. The study was approved by the Hospital’s
Ethics Committee.
Treatment with L. plantarum
Wounds were cleaned, irrigated with saline and treated with
topical applications of a whole culture of 105 L. plantarum
ATCC 10241/mL in log phase, which was previously grown
in De Man, Rogosa and Sharpe (MRS) broth for 5–6 h at
37C. The culture was spread on a gauze pad and applied to
the lesion, which was then covered with occlusive dressing.
The culture was applied once-daily over a period of 10 days.
Tolerable discomfort such as a burning sensation was
observed after the ﬁrst application of L. plantarum. The
lesions were clinically monitored and evaluated weekly by
the plastic surgeon.
Lesion biopsy samples
A 4-mm3 sample of tissue was divided into two parts.
One part of the biopsy was placed in RPMI (Roswell Park
Memorial Institute) 1640-HEPES Medium (Sigma, St Louis
MO, USA) with 100 mg/L of gentamicin, enzymatically
digested to obtain CUB were stained with haematoxilin
and eosin and terminal deoxynucleotidyl transferase biotin-
dUTP nick end labeling (TUNEL). In addition, IL-8 was
determined.
The other part of the biopsy was processed for microbial
evaluation by routine techniques. Forty-eight hours after the
10-day treatment period, wound and blood samples were
taken and incubated in MRS broth in an attempt to recover
L. plantarum.
PBPMN
Heparinized venous blood samples were collected from all
individuals. In the case of patients with ulcers, peripheral
blood samples were obtained before performing bacterio-
therapy. Neutrophils were isolated by dextran T-500 and Fi-
coll-Hypaque (Sigma) gradient centrifugation. The viability of
neutrophils was >96%. Finally, the cells were suspended at
106 PBPMN/mL in RPMI 1640-HEPES Medium supplemented
with foetal bovine serum 10% v/v (Gibco, Rockville, MD,
USA).
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Bacterial strains
The P. aeruginosa strains were a standard clinical isolate,
PA100, which was grown in Luria–Bertani medium (Gibco)
at 37C. Lactobacillus plantarum ATCC 10241 was grown in
MRS broth (Oxoid, Basingstoke, UK) at 37C.
PBPMN infection
The PBPMN suspension (106/mL) was cultured on 25-mm
diameter plates at 37C for 1 h and infected for 1 h with
2 · 107 P. aeruginosa PA 100. Cells were ﬁxed and IL-8 was
determined.
Lactobacillus plantarum interference
For the study of L. plantarum interference with P. aeruginosa,
PBPMN cultures (106/mL) were preincubated for 1 h at
37C with 2 · 105 L. plantarum. The viability of PBMN from
normal subjects, measured with trypan blue, was 76 ± 7%.
Cells were subsequently infected with 2 · 107 P. aeruginosa
for 1 h at 37C Thereafter, cells were ﬁxed and IL-8 was
determined. Apoptosis was determined by TUNEL. DNA
breaks were detected in situ by using a ﬂuorescein apoptosis
detection system kit Promega (Madison, WI, USA). Fluores-
cent cells were counted and expressed as percentage of ﬂuo-
rescent cells in a total count of 200 cells.
Intracellular IL-8 was determined by an immunoperoxidase
assay using anti human IL-8 goat polyclonal IgG antibodies
and an ABC staining system from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Stained cells were counted and
expressed as a percentage of positive cells in a count of 200
cells.
Statistical Analysis
Analysis of data was performed by using random effect in an
analysis of variance model with 95% conﬁdence intervals. To
compare the reduction in the wound area as a function of
time a multivariate analysis of variance (MANOVA) for repeated
measurements was used. p <0.05 was considered statistically
signiﬁcant.
Results
Wound healing
As shown in Table 1 the application of L. plantarum cul-
tures to wounds induced, in approximately 8 days (range,
6–10 days), a coverage of granulation tissue of more than
90% in 50% and 55% of the diabetic and non-diabetic
patients, respectively. After 30 days of treatment, a reduc-
tion of more than 90% of the lesion area was observed in
43% and 50% of the diabetics and non-diabetic patients,
respectively. As shown in Fig. 1a, the difference between
the values at day 0 and at day 30 of wound closure area
in both groups was statistically signiﬁcant (p <0.001) using
the MANOVA test.
This indicates a continuous healing process. No signiﬁcant
differences were observed between the diabetic and non-dia-
betic groups. The degrees of the reduction of the wound
areas 30 days after the start of treatment in the diabetic and
non-diabetic patients is shown in Fig. 1b.
Decrease in colony forming units (CFU) with treatment
Before treatment with L. plantarum, wound microbial counts
were 5 · 105 to 108 bacteria/g tissue. The bacteria isolated
included Staphylococcus aureus (45%), P. aeruginosa (35%) and
Staphylococcus epidermidis (15%), as well as others such as
Enterobacter cloacae, Klebsiella pneumoniae and Enterococcus
faecalis (5%). All these bacteria were bioﬁlm producers when
assayed for bioﬁlm formation in 96-well polyvinyl chloride
microtitre dishes stained with 0.1% crystal violet. The num-
ber of CFU was lower than 105 after 5 days of treatment
and dropped further (to <103) after 10 days (p <0.001). No
signiﬁcant differences were observed between diabetic and
non-diabetic patients (p 0.97). Forty-eight hours after the
end of the treatment with L. plantarum, this bacterial species
was not recovered from either peripheral blood or wound
samples.
TABLE 1. Effect of Lactobacillus plantarum treatment on
granulation tissue and area of ulcers of diabetic and non-
diabetic patients
Diabetics Non-diabetics
(n = 14) (n = 20)
Area coverage
with granulation
tissue
Percentage
(mean/range)
before (days 0) and
after 8 days
(range, 6–10)
of treatment
>90% n = 7; P = 0.50
day 0: 8% (0–12%)
day 8: 94% (90–100%)
n = 11; P = 0.55
day 0: 6% (0–10%)
day 8: 96% (92–100%)
<90% n = 7; P = 0.50
day 0: 7% (0–10%)
day 8: 39% (30–60%)
n = 9; P = 0.45
day 0: 8% (0–10%)
day 8: 43% (34–58%)
Ulcer area reduction
Percentage
(mean/range)
and size (cm2)
(median/
mean/(range) before/
after 30 days of
treatment
>80% n = 6; P = 0.43
93% (80–100%)
Before:
26/31.7/(25–50)
After: 1.2/2.2/(0–6.2)
n = 10; P = 0.50
92% (80–100)
Before:
38/39.5/(25–54)
After: 4/4.7/(0–10)
<80% n = 8; P = 0.57
52% (range, 35–70%)
Before:
46/45,8/(26–60)
After: 26/24/(15–30)
n = 10; P = 0.50
51% (range, 37–75)
Before:
48/47.6/(27–60)
After: 25/25/(11–37)
n, no of patients; P, proportion of patients.
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IL-8 changes in CUB with L. plantarum treatment
For the collection of CUB, samples were taken on days 0, 5
and 10 from the deep bed tissue. Most cells on days 0, 5 and
10 were PMN. The percentage of CUB positive for IL-8 in dia-
betics and non-diabetics was similar before treatment (day 0)
(Fig. 2), which is in agreement with a previous study (12),
although there is a tendency indicating lower levels in CUB
from the non-diabetic group (p 0.058).
IL-8 values increased after 5 days of treatment (p <0.001)
followed by a decrease after 10 days compared to 5 days of
treatment (p <0.05). These variations were independent of
the diabetic or non-diabetic condition of the patients. IL-8
was expressed mainly by PMN.
Cell population changes in CUB with L. plantarum
treatment.
Because the percentage values of different cellular popula-
tions of CUB from diabetic and non-diabetic patients showed
no signiﬁcant differences, both groups were combined.
Before L. plantarum treatment (day 0), 77 ± 13% of CUB
were PMN, which showed 25% necrosis, 7% apoptosis and
46% prolongation of life span morphology. After 10 days of
treatment, the percentage of PMN decreased (55 ± 19%)
and the number of macrophages (25 ± 12%) and ﬁbroblasts/
endothelial cells (19 ± 9%) increased. None of these cells
showed signs of necrosis or apoptosis.
Determination of IL-8 in PBPMN
Healthy individuals (N) had basal values of IL-8 positive
PBPMN that were signiﬁcantly lower than basal values of all
other groups, diabetic patients without ulcers (D), diabetic
patients with ulcers (DU) and non-diabetic patients with
ulcers (NDU) (p <0.001) (Fig. 3).
After P. aeruginosa infection, the percentage of IL-8 posi-
tive PBPMN was increased signiﬁcantly in groups N, D
and DU compared to basal values (p <0.001) and, to a
lesser extent, in the NDU group (p <0.01). There were
(a)
(b)
FIG. 1. (a) Ulcer area size and time of treatment in diabetic (ﬁlled
line) and non-diabetic (dotted line) patients. Each point represents
the mean ± SD wound area (diabetics n = 14; non-diabetics n = 20).
(b) Each symbol represents the percentage of wound reduction area
in each individual patient on day 30 after the start of the treatment.
Open squares, diabetics (D); ﬁlled squares, non-diabetics (ND).
FIG. 2. Percentage of interleukin (IL)-8-positive cells from the ulcer
bed from non-diabetics (ﬁlled squares) and diabetics (open squares)
with ulcers as a function of time. Boxes refer to the 25th (bottom)
and 75th (top) percentiles, and the median is the horizontal line
inside; fences refer to maximum and minimum values and open cir-
cles represent outliers. *Signiﬁcantly lower compared to days 5 and
10 (p <0.001) within the same group. **Signiﬁcantly higher compared
to day 10 (p <0.05) within the same group.
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no signiﬁcant differences among D, DU and NDU groups.
Preincubation of PBPMN with L. plantarum prior to infec-
tion with P. aeruginosa inhibited the number of IL-8 posi-
tive cells compared to cells that were not preincubated
only in the DU and NDU groups (p <0.001). No signiﬁ-
cant differences were observed between D and DU
patients.
Discussion
In the present study, we observed the effects of bacterio-
therapy on the modiﬁcation of the inﬂammatory response
and on infection in chronic venous ulcer leg wounds in dia-
betic and non-diabetic patients. The wounds showed polymi-
crobial infections with bioﬁlm-producing bacteria.
The application of L. plantarum caused a debridement and
granulation of wounds, a decrease both in the bacterial load
and in the area of the lesion in a signiﬁcant percentage of
diabetic and non-diabetic patients, with no signiﬁcant differ-
ences between the two groups. Previously, we demonstrated
that L. plantarum antagonized P. aeruginosa in vitro by inhibit-
ing the synthesis of quorum-sensing signals, bioﬁlm formation
and virulence factors. In an in vivo mouse experimental
model, L. plantarum decreased the infective capacity of P. aeru-
ginosa, enhancing the phagocytic activity and inhibiting the
apoptosis of PMN [9]. Other studies have shown the same
activity of Lactobacillus fermentum RC-14 on S. aureus infection
[8].
Lactobacillus plantarum treatment decreased apoptosis and
necrosis of neutrophils and promoted the appearance of
fresh PMN and other cells (i.e. ﬁbroblasts and endothelial) in
the ulcer bed. These cells were viable and exhibited changes
in IL-8 production. A decrease in P. aeruginosa-induced IL-8
production in PBPMN was only seen in patients with ulcers.
At present, we have no explanation for the differences
observed between individuals with and without ulcers. The
greater percentage of basal IL-8 in PBPMN found in diabetics
and patients with ulcers with respect to normal subjects
would predispose the former to inﬂammation.
Although it has been well established that, in diabetics,
basal inﬂammation states are increased, data on the produc-
tion of IL-8 and wound healing are contradictory [12]. We
found no signiﬁcant differences in the behaviour of the CUB
and PBPMN in diabetics and non-diabetics, most likely
because the former did not have advanced macro- and/or
microvascular complications.
The L. plantarum inhibition of IL-8 induced by P. aeruginosa
in PBPMN is in accordance with the effects observed in
human leukocytes when stimulated in vitro with P. aeruginosa
or L. plantarum. Lactobacillus plantarum preferentially induces
IL-12 and tumour necrosis factor-a, whereas P. aeruginosa
preferentially induces IL-10 and IL-6 [10]. Bacteria may have
intra- and interspecies communication for synergistic or
actions [13], as has been demonstrated in habitats such as
the gut and vagina [14] and the lung in cystic ﬁbrosis [15].
On the basis of these and previous ﬁndings obtained in
experimental models, we hypothesize that the antipathogenic
and bioﬁlm-disrupting activity of L. plantarum treatment regu-
lates IL-8 levels and modulates the entry and activity of the
newly-arrived PBPMN to the ulcer bed. A decrease in apop-
tosis and necrosis and a more effective phagocytosis would
decrease the number of bacteria, the debris and the inﬂam-
matory response. Consequently, the number of PMN would
decrease and would promote an increase in macrophages
and ﬁbroblasts, as well as tissue repair processes.
FIG. 3. Percentage of positive peripheral blood polymorphonuclear
neutrophils (PBPMN) for interleukin (IL)-8 production from different
groups of individuals: normal (N), diabetics without ulcers (D), non-
diabetics with ulcers (NDU), diabetics with ulcers (DU). The assay
was carried out with PBPMN under basal conditions (open squares)
and with PBPMN infected with Pseudomonas aeruginosa preincubated
either with (dark grey squares) or without Lactobacillus plantarum
(light grey squares). Boxes refer to the 25th (bottom) and 75th
(top) percentiles, and the median is the horizontal line inside; fences
refer to maximum and minimum values and open circles represent
outliers. Signiﬁcantly lower than the other basal values: #p <0.001.
Signiﬁcantly higher than the basal values within the same group:
*p <0.001; **p <0.01. Signiﬁcantly lower than P. aeruginosa infected
alone within the same group: §p <0.001.
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The importance of this treatment lies in the easy access
to and application of L. plantarum, its efﬁcacy, innocuousness
and low cost. In Argentinian hospitals, treatment is free and
low budgets make costly treatments impossible. Because the
present study comprises a ﬁrst approach to the subject, with
the limitation of the absence of comparator groups and the
small sample size, further studies investigating the treatment
of chronic infected wounds with L. plantarum are warranted.
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